Lamotrigine Tablet
Product Images NDC 76420-182

5 FDA label images from Asclemed Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 76420-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (307ce018 5a57 4dba 8b52 F2b69e428d93 789 2)

Image (307ce018 5a57 4dba 8b52 F2b69e428d93 789 2)
Lamotrigine 200 mg oral tablet, light blue and triangular in shape, imprinted with 'U U' on one side and '114' on the other. The tablet is labeled by Asclemed USA, Inc.*
FDA Label Image

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)
Chemical structure of lamotrigine, showing a chlorinated phenyl ring attached to a triazine ring with two amino substituents.*
FDA Label Image

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)
A Kaplan-Meier plot showing failure probability (%) over time in weeks for Lamotrigine and placebo groups. The graph includes censored data points and compares the failure probabilities between the two treatments across approximately 100 weeks.*
FDA Label Image

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)
A Kaplan-Meier failure probability curve chart comparing Lamotrigine and Placebo over weeks. The X-axis represents time in weeks (0 to 80), and the Y-axis represents failure probability in percentage (0% to 100%). The chart shows two curves labeled 'Lamotrigine' and 'Placebo,' with censored data points marked. The Placebo group shows a higher failure probability over time compared to the Lamotrigine group.*
FDA Label Image

60t Label-200 mg (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 04)

60t Label-200 mg (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 04)
Lamotrigine Tablets USP 200 mg label by Enovachem Pharmaceuticals, showing product NDC 76420-182-60 and quantity 60 tablets. The label includes manufacturer info for Unichem Pharmaceuticals (USA) Inc., product description as light blue trigonal tablets with biconvex/debossed markings, batch and lot numbers, and federal law dispensing caution. Storage instructions specify 20-25°C controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.